12:35:24 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for April 7, 2017

2017-04-07 20:58 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange closed up 2.42 points to 824.27 Friday, ending the week up 8.50 points. David Danziger's suspended capital pool shell, Aumento Capital V Corp. (AMN), has submitted a filing statement for its qualifying transaction, which is the acquisition of a licensed marijuana grower called WeedMD RX Inc. The shell, which has 1,939,682 shares issued, will issue 58,577,383 shares to its target's shareholders and debenture holders.

WeedMD's production facility is in Aylmer, Southern Ontario. In April, 2016, the company received its licence to grow marijuana, then in October it harvested its first crop. It now grows 40 strains. WeedMD is still waiting for its licence to sell the marijuana.

In November, 2016, WeedMD sold a $7.6-million private placement of 7,600 units at $1,000. Each unit comprised a $1,000 debenture and 1,333 warrants. For every $1,000 debenture, the holder will receive 1,333 shares of the resulting issuer. Warrants will be exercisable at $1 until November, 2018. There were 90 subscribers to the financing, including 71 in Ontario who bought a combined $4.46-million worth of units. Three unnamed subscribers in the Cayman Islands bought a combined $2.28-million worth of units. WeedMD had help in selling this private placement. It paid the following cash commissions: $131,728 to Canaccord Genuity Corp., $461,048 to Mark Attanasio's Eight Capital Markets and $65,864 to Cam Deacon's Echelon Wealth Partners.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed